Published in Infect Immun on December 01, 1989
Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis. PLoS One (2010) 1.47
Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization. Infect Immun (1990) 1.29
Morphological and biochemical study of cytoskeletal changes in cultured cells after extracellular application of Clostridium novyi alpha-toxin. Infect Immun (1992) 0.85
Recombinant Mucin-Type Fusion Proteins with a Galα1,3Gal Substitution as Clostridium difficile Toxin A Inhibitors. Infect Immun (2016) 0.75
Cellular internalisation of bacterial toxins. Cytotechnology (1991) 0.75
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun (1982) 6.88
The nuclear lamina is a meshwork of intermediate-type filaments. Nature (1986) 5.69
Molecular and cellular biology of intermediate filaments. Annu Rev Biochem (1988) 5.48
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Biological activities of toxins A and B of Clostridium difficile. Infect Immun (1982) 4.62
Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun (1988) 3.11
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun (1986) 2.89
Receptor-mediated endocytosis. Biochem J (1985) 2.73
Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun (1982) 2.65
Molecular and cellular effects of heat-shock and related treatments of mammalian tissue-culture cells. Cold Spring Harb Symp Quant Biol (1982) 2.18
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun (1986) 2.01
Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect Immun (1988) 2.00
Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture. Scand J Infect Dis Suppl (1980) 1.68
Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Gal alpha 1-3Gal beta 1-4GlcNAc sequences. Arch Biochem Biophys (1987) 1.51
Ultrastructural effects of Clostridium difficile toxin B on smooth muscle cells and fibroblasts. Exp Cell Res (1983) 1.46
Intranuclear actin bundles induced by dimethyl sulfoxide in interphase nucleus of Dictyostelium. J Cell Biol (1978) 1.44
Biochemical studies on the effect of Clostridium difficile toxin B on actin in vivo and in vitro. Infect Immun (1987) 1.34
Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile. Infect Immun (1984) 1.28
Cellular internalisation of Clostridium difficile toxin A. Microb Pathog (1987) 1.20
Dimethylsulfoxide and the ionophore A23187 affect the arrangement of actin and induce nuclear actin paracrystals in PtK2 cells. Exp Cell Res (1980) 1.19
Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity. Infect Immun (1981) 0.98
Interaction of Clostridium difficile toxin A with L cells in culture. Can J Microbiol (1984) 0.87
Intranuclear rod-shaped actin filament bundles in poorly differentiated axillary adenosquamous cell carcinoma. Cancer (1987) 0.78
A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250. Anal Biochem (1977) 14.08
A unique set of polypeptides is induced by gamma interferon in addition to those induced in common with alpha and beta interferons. Nature (1983) 2.68
The neuraminidase yield-reduction bioassay of human other interferons. Proc Soc Exp Biol Med (1975) 1.29
Actin and lamin comprised filaments in the nuclei of Chinese hamster ovary cells affected with Clostridium difficile enterotoxin A. Cytobios (1990) 0.99
Cytotoxicity of Clostridium difficile toxin A for human colonic and pancreatic carcinoma cell lines. Cancer Res (1992) 0.98
Enzymatic modifications of human fibroblast and leukocyte interferons. J Virol (1980) 0.96
Murine interferon-beta receptor-mediated endocytosis and nuclear membrane binding. Proc Natl Acad Sci U S A (1985) 0.95
Interferon bioassay: reduction in yield of myxovirus neuraminidases. J Gen Virol (1973) 0.94
Reaction of toxic shock syndrome toxin 1 with endothelium of human umbilical cord vein. Rev Infect Dis (1989) 0.90
Ultrastructural distribution of interferon receptor sites on mouse L fibroblasts grown in suspension: ganglioside blockade of ligand binding. Infect Immun (1983) 0.86
Discharge of aminoacyl-viral RNA by a factor from interferon-treated cells. Science (1976) 0.86
Internalization and transport of mouse beta-interferon into the cell nucleus. J Interferon Res (1986) 0.85
HuIFN-gamma antiviral activity correlates with immunological reactivity in a double-monoclonal antibody radiometric assay. J Interferon Res (1985) 0.82
Markedly enhanced production of gamma interferon in murine T lymphocytes treated with lentil lectin and the diterpene ester, mezerein. J Interferon Res (1984) 0.81
The cellular internalization of recombinant gamma interferon differs from that of natural interferon gamma. Biochem Biophys Res Commun (1988) 0.80
Transport of gamma-interferon into the cell nucleus may be mediated by nuclear membrane receptors. Biochem Biophys Res Commun (1986) 0.79
The influence of physicochemical factors on the thermal inactivation of murine interferon. Arch Virol (1975) 0.79
Quantitative analysis of mouse interferon-beta receptor-mediated endocytosis and nuclear entry. Cytobios (1988) 0.79
Ultrastructural localization of interferon receptors on the surfaces of cultured cells and erythrocytes. Infect Immun (1982) 0.79
Mouse beta-interferon reduces RNA efflux from isolated nuclei. J Interferon Res (1986) 0.78
Cytotoxicity of human beta-interferon for differentiating leukemic HL-60 cells. Cancer Res (1985) 0.77
Comparative enzyme kinetics of influenza neuraminidases with the synthetic substrate methoxyphenylneuraminic acid. Virology (1973) 0.77
Procedures for stabilization of interferons. Methods Enzymol (1981) 0.77
Interferon stabilization and enhancement by rare earth salts. J Gen Virol (1981) 0.76
Effect of chaotropic salts and protein denaturants on the thermal stability of mouse fibroblast interferon. J Gen Virol (1977) 0.75
Lanthanide ion enhancement of interferon binding to cells. Biochem Biophys Res Commun (1986) 0.75
Thermal and vortical stability of purified human fibroblast interferon. Adv Exp Med Biol (1978) 0.75
Quantification of low numbers of immunogold label on Lowicryl K4M sections. Cytobios (1988) 0.75
Interferon bioassay methods and the development of standard procedures: a critique and analysis of current observations. In Vitro Monogr (1974) 0.75
Virus yield-reduction assays for interferon with the influenza virus neuraminidase assay. Methods Enzymol (1981) 0.75
Stabilization of interferons. Tex Rep Biol Med (1977) 0.75
Interferon and antibody titrations using haemagglutinating Togaviridae and trypsinized human erythrocytes. J Virol Methods (1983) 0.75
Approaches to the stabilization of interferons. Tex Rep Biol Med (1983) 0.75
Diphtheria toxin receptor sites on membranes of cultured cells and erythrocytes demonstrated by fluorescence and electron microscopy. Cytobios (1984) 0.75
The reactivation of human interferons by guanidine thiocyanate. Experientia (1980) 0.75